From Name:
From Email:
To Name:
To Email:

Optional Message:


Fusion of CTLA-4 with HPV16 E7 and E6 enhanced potency of therapeutic HPV DNA vaccine

from PLOS One

Using CTLA-4 with E7 and E6 can enhance cellular and humoral immune responses against HPV16, according to a study published Sept. 29 in PLOS One. This strategy may provide useful ideas for developing therapeutic HPV DNA vaccines. However, further studies are needed to optimize the strategy. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063